MedTrace Logo

Healthcare Providers' Attitudes Toward Oncology Patients With Mental Disorders

NCT07748221 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 1000

Last updated 2026-08-05

No results posted yet for this study

Summary

ONCO-MinD is a multicentre, cross-sectional, non-interventional mixed-method study aimed at investigating healthcare providers' attitudes towards oncology patients with mental disorders in Italian cancer centres. The study will assess levels of mental health-related stigma among healthcare professionals and explore factors associated with these attitudes, including professional background, clinical setting, experience, and previous exposure to mental health conditions. Quantitative survey data collected using the Italian version of the Opening Minds Scale for Health Care Providers (OMS-HC) will be integrated with qualitative findings from semi-structured interviews to provide a comprehensive understanding of how stigma may influence clinical relationships, decision-making processes, and equity of cancer care.

Conditions

  • Stigma of Mental Illness
  • Cancer
  • Psychiatric Comorbidity

Interventions

OTHER

OMS-HC Questionnaire and Semi-Structured Interviews

Participants complete an anonymous questionnaire and, where selected, participate in a semi-structured interview for research data collection purposes. No clinical or behavioural intervention is administered.

Sponsors & Collaborators

  • Centro di Riferimento Oncologico - Aviano

    collaborator OTHER

  • Istituti Tumori Giovanni Paolo II

    collaborator NETWORK

  • Istituto Oncologico Veneto IRCCS

    lead OTHER

Principal Investigators

  • Carlo Alberto Camuccio, MSN; MSC · Istituto Oncologico Veneto - IOV IRCCS

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-09-01
Primary Completion
2027-09-30
Completion
2027-12-31

Countries

  • Italy

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07748221 on ClinicalTrials.gov